
### [NCIT:C9096](http://purl.obolibrary.org/obo/NCIT_C9096)
**Label:** Stage IV Cutaneous Melanoma AJCC v6 and v7

**Subclasses:** [NCIT:C8789](http://purl.obolibrary.org/obo/NCIT_C8789) (Stage IV Lentigo Maligna Melanoma AJCC v6 and v7), [NCIT:C8793](http://purl.obolibrary.org/obo/NCIT_C8793) (Stage IV Superficial Spreading Melanoma AJCC v6 and v7), 

**Class expressions from DL-Learner:**

- [NCIT:C40430](http://purl.obolibrary.org/obo/NCIT_C40430) (BRAF Gene Mutation) 75.00%
- [NCIT:C27971](http://purl.obolibrary.org/obo/NCIT_C27971) (Stage IV) 75.00%
- Thing 50.92%
- [NCIT:C28108](http://purl.obolibrary.org/obo/NCIT_C28108) (Disease Stage Qualifier) 39.43%
- [NCIT:C41009](http://purl.obolibrary.org/obo/NCIT_C41009) (Qualifier) 36.79%
- [NCIT:C27992](http://purl.obolibrary.org/obo/NCIT_C27992) (Disease Qualifier) 36.79%
- [NCIT:C20189](http://purl.obolibrary.org/obo/NCIT_C20189) (Property or Attribute) 36.79%
- [NCIT:C97927](http://purl.obolibrary.org/obo/NCIT_C97927) (Gene Mutant) 33.22%
- [NCIT:C36391](http://purl.obolibrary.org/obo/NCIT_C36391) (Molecular Genetic Variation) 28.64%
- [NCIT:C97926](http://purl.obolibrary.org/obo/NCIT_C97926) (Molecular Sequence Variation) 28.54%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 27.21%
- CP:0000037 0.00%
- CP:0000035 0.00%
- CP:0000028 0.00%
- CP:0000027 0.00%


